Ameritas Investment Partners Inc. increased its holdings in shares of Imperva Inc (NYSE:IMPV) by 18.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,940 shares of the software maker’s stock after buying an additional 464 shares during the quarter. Ameritas Investment Partners Inc.’s holdings in Imperva were worth $141,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also made changes to their positions in IMPV. UBS Asset Management Americas Inc. grew its stake in Imperva by 107.3% during the 1st quarter. UBS Asset Management Americas Inc. now owns 13,889 shares of the software maker’s stock worth $570,000 after buying an additional 7,189 shares during the last quarter. Teachers Advisors LLC lifted its position in Imperva by 2.6% during the 1st quarter. Teachers Advisors LLC now owns 48,482 shares of the software maker’s stock worth $1,990,000 after acquiring an additional 1,220 shares during the period. Vanguard Group Inc. lifted its position in Imperva by 4.6% during the 1st quarter. Vanguard Group Inc. now owns 2,339,441 shares of the software maker’s stock worth $96,033,000 after acquiring an additional 102,779 shares during the period. Geode Capital Management LLC lifted its position in Imperva by 8.2% during the 1st quarter. Geode Capital Management LLC now owns 233,341 shares of the software maker’s stock worth $9,578,000 after acquiring an additional 17,722 shares during the period. Finally, Morgan Stanley lifted its position in Imperva by 85.9% during the 1st quarter. Morgan Stanley now owns 220,292 shares of the software maker’s stock worth $9,044,000 after acquiring an additional 101,772 shares during the period. Hedge funds and other institutional investors own 92.72% of the company’s stock.
In related news, Director Anthony J. Bettencourt sold 99,598 shares of Imperva stock in a transaction dated Thursday, August 24th. The stock was sold at an average price of $43.59, for a total value of $4,341,476.82. Following the completion of the transaction, the director now owns 99,598 shares in the company, valued at approximately $4,341,476.82. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 2.20% of the company’s stock.
A number of analysts have commented on the company. Piper Jaffray Companies reaffirmed a “neutral” rating and set a $58.00 price target on shares of Imperva in a research report on Friday, October 13th. BidaskClub raised Imperva from a “sell” rating to a “hold” rating in a research report on Tuesday, September 12th. Stifel Nicolaus reaffirmed a “hold” rating and set a $47.00 price target on shares of Imperva in a research report on Friday, July 14th. KeyCorp reaffirmed a “hold” rating on shares of Imperva in a research report on Tuesday, October 24th. Finally, William Blair cut Imperva from an “outperform” rating to a “market perform” rating in a research report on Tuesday, October 10th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $53.50.
Imperva Inc (IMPV) opened at $42.60 on Monday.
ILLEGAL ACTIVITY WARNING: This report was first reported by Community Financial News and is the property of of Community Financial News. If you are viewing this report on another domain, it was copied illegally and reposted in violation of U.S. & international copyright law. The correct version of this report can be accessed at https://www.com-unik.info/2017/11/06/imperva-inc-impv-shares-bought-by-ameritas-investment-partners-inc.html.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
What are top analysts saying about Imperva Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Imperva Inc and related companies.